Literature DB >> 25659638

Correlation of the plasma levels of soluble RAGE and endogenous secretory RAGE with oxidative stress in pre-diabetic patients.

Minglian Huang1, Yanyan Que1, Xingping Shen2.   

Abstract

BACKGROUND: Soluble RAGE (sRAGE), endogenous secretory RAGE (esRAGE) and oxidative stress played important roles in the pathogenesis of diabetes and its complications. The changes in sRAGE and esRAGE during pre-diabetes were indefinite.
METHODS: Patients were divided into NGT, pre-diabetes (pre-DM), and newly diagnosed diabetes mellitus (DM) groups according to blood glucose levels. The levels of sRAGE, esRAGE, 8-isoprostaglandin F2α (8-iso-PGF2α), superoxide dismutase (SOD) activity, total antioxidant capacity (TAOC), malondialdehyde (MDA), and other related indicators were then assessed.
RESULTS: sRAGE and esRAGE in the pre-DM and DM groups were significantly lower than in the NGT group (p<0.05). In the pre-DM group, sRAGE was positively correlated with esRAGE (r=0.382, P=0.007), and negatively correlated with homeostasis model assessment-estimated insulin resistance (HOMA-IR), MDA, and 8-iso-PGF2α (r=-0.314, -0.313, and -0.34, P=0.028, 0.028, and 0.016, respectively). The concentration of esRAGE was positively correlated with sRAGE and TAOC (r=0.382 and 0.598, and P=0.007, <0.001), and negatively correlated with MDA (r=-0.397, P=0.005).
CONCLUSIONS: Changes in sRAGE, esRAGE, and oxidative stress occurred in pre-diabetic patients. sRAGE and esRAGE might play an essential role in the balance between oxidative stress and antioxidant defense. THE SIGNIFICANT FINDINGS OF THE STUDY: Changes in sRAGE, esRAGE, and oxidative stress occurred in pre-diabetic patients. THIS STUDY ADDS: sRAGE, esRAGE, and oxidative stress are altered early during pre-diabetes. sRAGE and esRAGE may have played different roles in the balance between oxidative stress and the antioxidant defense.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Oxidative stress; Pre-diabetes; esRAGE; sRAGE

Mesh:

Substances:

Year:  2014        PMID: 25659638     DOI: 10.1016/j.jdiacomp.2014.12.007

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  9 in total

1.  Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes.

Authors:  Edwin R Miranda; Vikram S Somal; Jacob T Mey; Brian K Blackburn; Edward Wang; Sarah Farabi; Kristian Karstoft; Ciaran E Fealy; Sangeeta Kashyap; John P Kirwan; Laurie Quinn; Thomas P J Solomon; Jacob M Haus
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-08-15       Impact factor: 4.310

2.  A robust machine learning framework to identify signatures for frailty: a nested case-control study in four aging European cohorts.

Authors:  David Gomez-Cabrero; Stefan Walter; Imad Abugessaisa; Rebeca Miñambres-Herraiz; Lucia Bernad Palomares; Lee Butcher; Jorge D Erusalimsky; Francisco Jose Garcia-Garcia; José Carnicero; Timothy C Hardman; Harald Mischak; Petra Zürbig; Matthias Hackl; Johannes Grillari; Edoardo Fiorillo; Francesco Cucca; Matteo Cesari; Isabelle Carrie; Marco Colpo; Stefania Bandinelli; Catherine Feart; Karine Peres; Jean-François Dartigues; Catherine Helmer; José Viña; Gloria Olaso; Irene García-Palmero; Jorge García Martínez; Pidder Jansen-Dürr; Tilman Grune; Daniela Weber; Giuseppe Lippi; Chiara Bonaguri; Alan J Sinclair; Jesper Tegner; Leocadio Rodriguez-Mañas
Journal:  Geroscience       Date:  2021-02-18       Impact factor: 7.713

3.  The Product of Red Blood Cells and Hematocrit Can Be Used as a Novel Indicator of Impaired Fasting Blood Glucose Status.

Authors:  Ling Feng; Haishan Chen; Jianhui Chen; Chongxiang Xiong; Xiaofei Shao; Xin Wang; Jing Ning; Zhicong Xiang; Xuan Wang; Tong Chen; Hua Xiao; Hongjuan Tang; Xiaolin Li; Guobao Hong; Hequn Zou
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-27       Impact factor: 3.168

Review 4.  The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes.

Authors:  Jorge D Erusalimsky
Journal:  Redox Biol       Date:  2021-03-29       Impact factor: 11.799

5.  Effect of rosiglitazone on inflammatory cytokines and oxidative stress after intensive insulin therapy in patients with newly diagnosed type 2 diabetes.

Authors:  Juan Li; Xingping Shen
Journal:  Diabetol Metab Syndr       Date:  2019-05-03       Impact factor: 3.320

6.  Expression of the receptor of advanced glycation end-products (RAGE) and membranal location in peripheral blood mononuclear cells (PBMC) in obesity and insulin resistance.

Authors:  Elizabeth Del Carmen Ruelas Cinco; Bertha Ruíz Madrigal; José Alfredo Domínguez Rosales; Montserrat Maldonado González; Lucía De la Cruz Color; Sandra Margarita Ramírez Meza; José Rodrigo Torres Baranda; Erika Martínez López; Zamira Helena Hernández Nazará
Journal:  Iran J Basic Med Sci       Date:  2019-06       Impact factor: 2.699

7.  Inhibition of Endoplasmic Reticulum Stress Improves Acetylcholine-Mediated Relaxation in the Aorta of Type-2 Diabetic Rats.

Authors:  Sagir Mustapha; Ahmad Khusairi Azemi; Wan Amir Nizam Wan Ahmad; Aida Hanum Ghulam Rasool; Mohd Rais Mustafa; Siti Safiah Mokhtar
Journal:  Molecules       Date:  2022-08-11       Impact factor: 4.927

8.  Impact of Dairy Intake on Plasma F2-IsoProstane Profiles in Overweight Subjects with Hyperinsulinemia: A Randomized Crossover Trial.

Authors:  Leila Khorraminezhad; Jean-François Bilodeau; Karine Greffard; Jessica Larose; Iwona Rudkowska
Journal:  Nutrients       Date:  2021-06-18       Impact factor: 5.717

9.  Selected Oxidative Stress Markers in Colorectal Cancer Patients in Relation to Primary Tumor Location-A Preliminary Research.

Authors:  Karolina Janion; Elżbieta Szczepańska; Ewa Nowakowska-Zajdel; Joanna Strzelczyk; Angelika Copija
Journal:  Medicina (Kaunas)       Date:  2020-01-21       Impact factor: 2.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.